Paper36770883
Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy.
Wahab S and 8 others. Molecules, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy. Papers, record 36770883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36770883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanostructures | Major topic |
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Nanotechnology | |
| Immunotherapy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RGP.1/343/43. | King Khalid University | PubMed |
Source PubMed
References176
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26748421 | The immune system and cancer evasion strategies: therapeutic concepts. | J Intern Med | 2016 | https://conductscience.org/library/papers/26748421 | PubMed |
| 2 | 21690347 | Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21690347 | PubMed |
| 3 | 18200966 | [Subpopulations of peripheral blood dendritic cells during chemotherapy of ovarian cancer]. | Ginekol Pol | 2007 | https://conductscience.org/library/papers/18200966 | PubMed |
| 4 | 31755508 | The vacuolization of macrophages induced by large amounts of inorganic nanoparticle uptake to enhance the immune response. | Nanoscale | 2019 | https://conductscience.org/library/papers/31755508 | PubMed |
| 5 | 25035633 | Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. | J Pharm Bioallied Sci | 2014 | https://conductscience.org/library/papers/25035633 | PubMed |
| 6 | 31195861 | Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease. | J Immunotoxicol | 2019 | https://conductscience.org/library/papers/31195861 | PubMed |
| 7 | 26826436 | "Eat me" imaging and therapy. | Adv Drug Deliv Rev | 2016 | https://conductscience.org/library/papers/26826436 | PubMed |
| 8 | 20692033 | The promotion of type 1 T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion. | Biomaterials | 2010 | https://conductscience.org/library/papers/20692033 | PubMed |
| 9 | 18754745 | Nanotechnology for drug delivery: the perfect partnership. | Expert Opin Drug Deliv | 2008 | https://conductscience.org/library/papers/18754745 | PubMed |
| 10 | 21185594 | Cytotoxicity of, and innate immune response to, size-controlled polypyrrole nanoparticles in mammalian cells. | Biomaterials | 2011 | https://conductscience.org/library/papers/21185594 | PubMed |
| 11 | 23345940 | Prognostic value of innate and adaptive immunity in colorectal cancer. | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/23345940 | PubMed |
| 12 | 15935507 | Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. | J Control Release | 2005 | https://conductscience.org/library/papers/15935507 | PubMed |
| 13 | 20698555 | Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. | ACS Nano | 2010 | https://conductscience.org/library/papers/20698555 | PubMed |
| 14 | 25634484 | Size and rigidity of cylindrical polymer brushes dictate long circulating properties in vivo. | ACS Nano | 2015 | https://conductscience.org/library/papers/25634484 | PubMed |
| 15 | 24724793 | Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24724793 | PubMed |
| 16 | 29491709 | Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles. | Int J Nanomedicine | 2018 | https://conductscience.org/library/papers/29491709 | PubMed |
| 17 | 34474029 | Current trends and future perspectives of nanomedicine for the management of colon cancer. | Eur J Pharmacol | 2021 | https://conductscience.org/library/papers/34474029 | PubMed |
| 18 | 24248387 | Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24248387 | PubMed |
| 19 | 30287266 | The application of nanotechnology in immune checkpoint blockade for cancer treatment. | J Control Release | 2018 | https://conductscience.org/library/papers/30287266 | PubMed |
| 20 | 26806856 | Impact of particle elasticity on particle-based drug delivery systems. | Adv Drug Deliv Rev | 2017 | https://conductscience.org/library/papers/26806856 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42333286 | Biomimetic Polymer-Based Nanomaterials for Immune-Responsive Hepatocellular Carcinoma Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42333286 | PubMed |
| 42193291 | Immunomodulatory Nanomaterials: Design Strategies, Mechanisms, Biomedical Applications, and Future Perspectives. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193291 | PubMed |
| 41291133 | A review: advances of resveratrol co-delivery biomaterials-based system in anti-tumor therapy. | J Mater Sci Mater Med | 2025 | https://conductscience.org/library/papers/41291133 | PubMed |
| 40142960 | Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40142960 | PubMed |
| 37691916 | The role of macrophages in rosacea: implications for targeted therapies. | Front Immunol | 2023 | https://conductscience.org/library/papers/37691916 | PubMed |
| 37047572 | Carbon Nanomaterials: Emerging Roles in Immuno-Oncology. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047572 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36770883
GET https://conductscience.org/api/papers/v1/36770883/references?page=2